Pharmaceutical
FDA MedWatch Drug Alerts
- Audience: Health Care Professional Santa Fe Springs, California – April 07, 2026 – Blaine Labs, Inc. is voluntarily recalling three (3) lot numbers of Wound Care Gel products, 1 oz. & 3 oz. (0.1% Benzalkonium Chloride) to the…
- Audience: Consumer April 07, 2026 Ferndale, Michigan. Nalpac is voluntarily recalling DTF Sexual Chocolate it purchased and resold. The products have been found to contain sildenafil and tadalafil. Nalpac is not the manufacturer of this…
- Audience: Health Care Professional March 31, 2026 – FDA Identifies Cases of Serious Liver Injury in Patients Taking Tavneos (avacopan) for Severe Active Anti-neutrophil Cytoplasmic Autoantibody (ANCA)-associated Vasculitis What Is FDA Doing? FDA…
- Audience: Consumer March 30, 2026 – Flushing, New York, Aphreseller (Ebay seller ID), Buy-herbal.com is recalling all lots of Kian Pee Wan capsules to the consumer level. FDA analysis has found that the product contains the undeclared drug…
- Audience: Health Care Professional, Pharmacy March 24, 2026 – Bridgewater, New Jersey, Amneal Pharmaceuticals LLC is voluntarily recalling one lot of Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag, to the hospital level. A…
New Drug Approvals
- RAHWAY, N.J.–(BUSINESS WIRE) April 21, 2026 — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved Idvynso, a new, two-drug single-tablet regimen of…
- NASHVILLE, Tenn., April 16, 2026 /PRNewswire/ — Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced it has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication…
- SAN DIEGO–(BUSINESS WIRE) April 13, 2026 — Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has approved Filspari (sparsentan) to reduce proteinuria in adult and pediatric patients aged…
- SANTA MONICA, Calif. – April 2, 2026 – The U.S. Food and Drug Administration (FDA) has granted traditional (full) approval to Kite’s CAR T-cell therapy, Tecartus (brexucabtagene autoleucel), for adult patients with relapsed or…
- TARRYTOWN, N.Y., April 02, 2026 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the extension of dosing intervals for Eylea HD® (aflibercept) up to…
New Drug Applications
- WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company received a complete…
- MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the Company's…
- CAMBRIDGE, Mass., April 7, 2026 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the…
- NOVATO, Calif., April 02, 2026 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the U.S. Food and Drug Administration (FDA or the Agency) has accepted for review the resubmitted Biologics License Application (BLA)…
- MENLO PARK, CA, April 1, 2026 – Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has extended the…
Clinical Trial Results
- TARRYTOWN, N.Y., April 21, 2026 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced detailed positive results from the Phase 3 NIMBLE trial evaluating investigational cemdisiran in adults with generalized…
- MIAMI, April 20, 2026 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, today…
- 20 April 2026 — Positive high-level results from the pivotal Phase III MIRANDA trial showed potential first-in-class tozorakimab demonstrated a statistically significant and clinically meaningful reduction in the annualised rate of…
- EMERYVILLE, Calif., April 20, 2026 (GLOBE NEWSWIRE) — Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced positive…
- Bagsværd, Denmark, 20 April 2026 – Novo Nordisk today announced the topline results from HIBISCUS, a pivotal phase 3 trial of once-daily oral etavopivat in adults and adolescents with sickle cell disease (SCD). The results showed that…
Daily Med News
- TUESDAY, April 21, 2026 — A kid's toy designed for learning and play is being pulled from the market over safety concerns. Officials say parts of the ATOYUS Children’s Activity Cubes can fall off, posing a choking risk for young…
- TUESDAY, April 21, 2026 — "Do I really need chemotherapy?" "Is this natural remedy safer?" "Does eating sugar cause cancer?" As more people turn to artificial intelligence (AI) for quick answers to health questions like these, a new study…
- TUESDAY, April 21, 2026 — A former U.S. surgeon general is weighing in on the president’s pick to lead the U.S. Centers for Disease Control and Prevention (CDC), calling Dr. Erica Schwartz highly qualified while warning of some potential…
- TUESDAY, April 21, 2026 — Health officials in some states are warning shoppers to avoid certain cantaloupes amid concerns they may carry Salmonella. The recall, announced by the U.S. Food and Drug Administration (FDA), involves fruit produced…
- TUESDAY, April 21, 2026 — Assistance dogs are more active caretakers for their impaired or ill humans than we give them credit for, a new study says. These service dogs not only help people with practical tasks, but actively contribute to…
News for Health Professionals
- TUESDAY, April 21, 2026 — Extreme weather may increase the risk of cardiovascular disease, according to a study published online April 21 in the American Journal of Preventive Medicine. Linjiang Wei, Ph.D., from Xiamen University in China, and…
- TUESDAY, April 21, 2026 — For older adults, longer and more frequent daytime napping is associated with higher all-cause mortality, according to a study published online April 20 in JAMA Network Open. Chenlu Gao, Ph.D., from Mass General Brigham…
- TUESDAY, April 21, 2026 — Young patients with lung cancer have significantly higher fruit, vegetable, and whole grain consumption than the U.S. reference, according to a study presented at the annual meeting of the American Association for Cancer…
- TUESDAY, April 21, 2026 — Having a longer reproductive span is associated with better cognitive trajectories, while menopausal hormone therapy (MHT) use within 10 years of menopause is associated with faster cognitive decline, according to a study…
- TUESDAY, April 21, 2026 — Men with severely impaired fertility may have an increased risk for colorectal and thyroid cancer, according to a study published online Feb. 21 in the European Journal of Epidemiology. Peter Zarén, from Lund…
